Table 3 Growth parameters and medical treatment from discharge to follow-up at 18–24 months corrected age.
Seizure (-) (N = 7,174) | Seizure (+) (N = 425) | P-value | |
|---|---|---|---|
Follow up rate after discharge | 7,174/9,344 (76.8%) | 425/536 (79.3%) | 0.179 |
Visit | 5,998 (83.6%) | 337 (79.3%) | 0.020 |
No visit | 1,176 (16.4%) | 88 (20.7%) | |
Visit to other hospital | 118 (10.0%) | 26 (29.5%) | < 0.001 |
Telephone survey | 992 (84.4%) | 27 (30.7%) | |
Admitted to hospital | 7 (0.6%) | 1 (1.1%) | |
Post-discharge mortality | 59 (5.0%) | 34 (38.6%) | |
GA, weeks | 29+ 1 [27+ 3, 31+ 0] | 26+ 2 [24+ 5, 28+ 1] | < 0.001 |
Birthweight, g | 1160 [930, 1340] | 860 [700, 1100] | < 0.001 |
Male gender | 3,537 (49.3%) | 256 (60.2%) | < 0.001 |
Growth at 18-24months corrected age | |||
Weight | N = 6,547 | N = 359 | < 0.001 |
<10th | 1,204 (18.4%) | 147 (40.9%) | |
10th -90th | 4,937 (75.4%) | 203 (56.5%) | |
>90th | 406 (6.2%) | 9 (2.5%) | |
Height | N = 6,012 | N = 339 | < 0.001 |
<10th | 1,261 (21.0%) | 123 (36.3%) | |
10th -90th | 4,297 (71.5%) | 195 (57.5%) | |
>90th | 454 (7.6%) | 21 (6.2%) | |
Head circumference | N = 5,098 | N = 284 | < 0.001 |
<10th | 1,038 (20.4%) | 144 (50.7%) | |
10th -90th | 3,588 (70.4%) | 137 (48.2%) | |
>90th | 472 (9.3%) | 3 (1.1%) | |
Medical treatment after NICU discharge | |||
Oxygen treatment | 737/6,925 (10.6%) | 115/366 (31.4%) | < 0.001 |
Ventilator care | 207/6,922 (3.0%) | 23/365 (6.3%) | < 0.001 |
Tracheostomy | 36/6,930 (0.5%) | 9/366 (2.5%) | < 0.001 |
Nasogastric tube feeding | 317/6,930 (4.6%) | 76/366 (20.8%) | < 0.001 |
Ventriculo-peritoneal shunt | 48/6,930 (0.7%) | 63/365 (17.3%) | < 0.001 |
Anti-epileptic medication | 77/6,929 (1.1%) | 118/365 (32.3%) | < 0.001 |
Rehabilitation treatment | 2,226/6,889 (32.3%) | 284/364 (78.0%) | < 0.001 |
Language treatment | 418/6,850 (6.1%) | 58/349 (16.6%) | < 0.001 |
Pulmonary HT medication | 46/2,749 (1.7%) | 17/137 (12.4%) | < 0.001 |
Readmission | 3,265/6,867 (47.5%) | 246/360 (68.3%) | < 0.001 |
Brain CT/MRI after NICU discharge | |||
Performed | 728/6,878 (10.6%) | 145/365 (39.7%) | < 0.001 |
Abnormal | 405/728 (55.6%) | 125/145 (86.2%) | < 0.001 |